Yassine Bendiabdallah

Yassine Bendiabdallah

Director/Miembro de la Junta en GENFLOW BIOSCIENCES PLC .
Commercial Services
Consumer Services
Health Technology

Perfil

Yassine Bendiabdallah is the founder.
Dr. Bendiabdallah was the founder of Pasithea Therapeutics Corp., holding the title of COO, Director & Head-UK Clinics since 2020.
Dr. Bendiabdallah is also the founder of Purecare Ltd., Androgenix Pharmaceuticals Ltd., Zen Healthcare Center, Inc. Dr. Bendiabdallah is currently an Independent Non-Executive Director at Genflow Biosciences Plc since 2023, a Member of The Royal Society of Chemistry, and a Member of the Royal Pharmaceutical Society.
Dr. Bendiabdallah obtained a doctorate from the University of London in 2010 and a graduate degree from King's College London in 2006.

Cargos activos de Yassine Bendiabdallah

EmpresasCargoInicio
GENFLOW BIOSCIENCES PLC Director/Miembro de la Junta 11/05/2023
Purecare Ltd.
Director Ejecutivo -
Corporate Officer/Principal -
Corporate Officer/Principal -
Fundador -

Antiguos cargos conocidos de Yassine Bendiabdallah.

EmpresasCargoFin
PASITHEA THERAPEUTICS CORP. Fundador 14/09/2022
Androgenix Pharmaceuticals Ltd.
Director Ejecutivo -
Ver el detalle de la experiencia de Yassine Bendiabdallah.

Formación de Yassine Bendiabdallah.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

87

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Purecare Ltd.

Androgenix Pharmaceuticals Ltd.

Health Services

  1. Bolsa de valores
  2. Insiders
  3. Yassine Bendiabdallah